Researchers reveal high temperature stability of exotic silicon phases
Differences in the raman spectra of silicon samples as a function of temperature uncovers separate phases
Differences in the raman spectra of silicon samples as a function of temperature uncovers separate phases
Initial twelve-month collaboration successfully identifies hit compounds and progresses into hit-to-lead optimization phase
New approach to ion exchange membrane design uses low-cost plastic membranes with hydrophilic pores
Rigaku is showcasing its XRD, XRF and Raman instrumentation at the 2019 Materials Research Society Fall Meeting & Exhibit in Boston
Abcam's new offering enables proteomic studies by providing
The approach lays the foundation for novel ways to map connections across different brain regions
Harvard, MIT, and various teaching hospitals team up with industry partners to launch new center for regenerative therapies
Series of free explainer infographics summarize headspace, SPME, high capacity sorptive extraction (HiSorb) and thermal desorption
BINDER named one of the most innovative companies in Germany
Researcher Meritxell Huch awarded the BINDER Innovation Prize
Automation customers throughout the region gain convenient access to hands-on education and ongoing support services
Clinical trial will evaluate the safety and immunogenicity of Entervax™
New ZEISS iCeMS Innovation Core collaborative laboratory opened
Money will help fund the international DUNE experiment
New aerodynamic materials developed are sent to investigate erosion properties in low earth orbit
Abbott is making this new strain accessible to the research community to evaluate its impact on diagnostics, treatment and potential vaccines
The introduction of a digital alert system to monitor patients with sepsis has led to a reduction in deaths and hospital stays
International panel of pathologists drive progressive agenda on the role of pathology in transforming cancer diagnostics and improving patient care
Proximity will facilitate local and international sponsor access to Kayentis’ eCOA services for mid- to later-stage clinical trials
Developing accident tolerant fuels to make nuclear fission safer in the event of accident scenarios